Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regression Toward the Mean

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...

Bias

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cataracts in Atomic-bomb Survivors More than 70 Years after Radiation Exposure.

Radiation research·2026

Same author

Recent evolution of risk analyses in atomic bomb survivor studies: new methods and applications.

Carcinogenesis·2025

Same author

Calculations of Mean Quality Factors and Their Implications for Organ-specific Relative Biological Effectiveness (RBE) in Analysis of Radiation-related Risk in the Atomic Bomb Survivors.

Radiation research·2025

Same author

A note on potential gains in precision of radiation risk estimates from joint analysis.

Scientific reports·2024

Same author

Relationship Between Radiation Dose and Markers of Insulin Resistance and Inflammation in Atomic Bomb Survivors.

The Journal of clinical endocrinology and metabolism·2024

Same author

The Use of Joint Models in Analysis of Aggregate Endpoints in RERF Cohort Studies.

Radiation research·2024

Search research articles

Related Experiment Video

Updated: Jun 9, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Bias in Low Dose Risk Estimation due to the Constant RBE Assumption in RERF Studies.

Radiation Research

|April 1, 2026

Summary

The constant relative biological effectiveness (RBE) assumption in atomic bomb radiation exposure analysis may bias gamma radiation risk estimates. This bias is particularly relevant for neutron radiation dose assessments in the low dose range.

Area of Science:

Radiation biology
Epidemiology
Risk assessment

Background:

Atomic bomb survivors in Hiroshima and Nagasaki were exposed to both gamma and neutron radiation.
Radiation Effects Research Foundation (RERF) data analysis typically assumes a constant relative biological effectiveness (RBE) for neutron radiation to estimate gamma radiation risk.

Purpose of the Study:

To investigate the potential bias in gamma radiation risk estimation arising from the assumption of a constant RBE for neutron radiation.
To analyze the impact of RBE constancy on excess relative risk (ERR) in different dose ranges.

Main Methods:

Analytical investigation of bias resulting from constant RBE assumption across various organ doses.
Simulation study to confirm analytical findings.
Consideration of dose-response curvatures for gamma and neutron radiation.

More Related Videos

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Published on: May 2, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Jun 9, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Effective Analysis of Human Exposure Conditions with Body-worn Dosimeters in the 2.4 GHz Band

Published on: May 2, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Main Results:

The assumption of a constant RBE can lead to significant bias in estimating excess risk from gamma radiation.
Bias is dependent on the assumed RBE, true limiting maximum RBE, dose-response curvatures, and dose distribution.
Even matching the assumed RBE to the true limiting maximum RBE does not eliminate bias if dose response has curvature.

Conclusions:

The assumption of constant RBE in RERF data analysis may introduce bias when estimating gamma radiation risks.
Bias is generally small at very low doses (e.g., 0.1 Gy) but can be significant at higher doses.
Careful consideration of potential RBE-related bias is crucial when interpreting risk estimates from radiation exposure studies.